John Sprague
2018
In 2018, John Sprague earned a total compensation of $1.5M as Chief Financial Officer at T2 Biosystems.
Compensation breakdown
| Non-Equity Incentive Plan | $120,312 |
|---|---|
| Option Awards | $713,639 |
| Salary | $323,526 |
| Stock Awards | $336,616 |
| Other | $3,000 |
| Total | $1,497,093 |
Sprague received $713.6K in option awards, accounting for 48% of the total pay in 2018.
Sprague also received $120.3K in non-equity incentive plan, $323.5K in salary, $336.6K in stock awards and $3K in other compensation.
Rankings
In 2018, John Sprague's compensation ranked 7,168th out of 14,244 executives tracked by ExecPay. In other words, Sprague earned more than 49.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,168 out of 14,244 | 50th |
Division Manufacturing | 2,769 out of 5,762 | 52nd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 345 out of 849 | 59th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 194 out of 547 | 65th |
Industry Surgical and Medical Instruments and Apparatus | 120 out of 348 | 66th |
Source: SEC filing on April 26, 2019.
Sprague's colleagues
We found two more compensation records of executives who worked with John Sprague at T2 Biosystems in 2018.